859 related articles for article (PubMed ID: 19591892)
21. Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: an enabling study for independent validation as an alternative method.
Billinton N; Hastwell PW; Beerens D; Birrell L; Ellis P; Maskell S; Webster TW; Windebank S; Woestenborghs F; Lynch AM; Scott AD; Tweats DJ; van Gompel J; Rees RW; Walmsley RM
Mutat Res; 2008 May; 653(1-2):23-33. PubMed ID: 18450500
[TBL] [Abstract][Full Text] [Related]
22. An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening.
Van Gompel J; Woestenborghs F; Beerens D; Mackie C; Cahill PA; Knight AW; Billinton N; Tweats DJ; Walmsley RM
Mutagenesis; 2005 Nov; 20(6):449-54. PubMed ID: 16291732
[TBL] [Abstract][Full Text] [Related]
23. The GADD45a-GFP GreenScreen HC assay.
Walmsley RM; Tate M
Methods Mol Biol; 2012; 817():231-50. PubMed ID: 22147576
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds.
Olaharski A; Albertini S; Kirchner S; Platz S; Uppal H; Lin H; Kolaja K
Mutat Res; 2009 Jan; 672(1):10-6. PubMed ID: 18812235
[TBL] [Abstract][Full Text] [Related]
25. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins.
Liu X; Kramer JA; Swaffield JC; Hu Y; Chai G; Wilson AG
Mutat Res; 2008 May; 653(1-2):63-9. PubMed ID: 18485802
[TBL] [Abstract][Full Text] [Related]
26. Screening for genotoxicity using the DRAG assay: investigation of halogenated environmental contaminants.
Johansson F; Allkvist A; Erixon K; Malmvärn A; Nilsson R; Bergman A; Helleday T; Jenssen D
Mutat Res; 2004 Sep; 563(1):35-47. PubMed ID: 15324747
[TBL] [Abstract][Full Text] [Related]
27. Validation of a high-throughput in vitro alkaline elution/rat hepatocyte assay for DNA damage.
Gealy R; Wright-Bourque JL; Kraynak AR; McKelvey TW; Barnum JE; Storer RD
Mutat Res; 2007 Apr; 629(1):49-63. PubMed ID: 17306613
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the toxicity forecasting capability of EPA's ToxCast Phase I data: can ToxCast in vitro assays predict carcinogenicity?
Benigni R
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(3):201-12. PubMed ID: 24024519
[TBL] [Abstract][Full Text] [Related]
29. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
Brambilla G; Martelli A
Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
[TBL] [Abstract][Full Text] [Related]
30. Validation of a human cell based high-throughput genotoxicity assay 'Anthem's Genotoxicity screen' using ECVAM recommended lists of genotoxic and non-genotoxic chemicals.
Rajakrishna L; Krishnan Unni S; Subbiah M; Sadagopan S; Nair AR; Chandrappa R; Sambasivam G; Sukumaran SK
Toxicol In Vitro; 2014 Feb; 28(1):46-53. PubMed ID: 23850743
[TBL] [Abstract][Full Text] [Related]
31. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
Ku WW; Aubrecht J; Mauthe RJ; Schiestl RH; Fornace AJ
Toxicol Sci; 2007 Sep; 99(1):20-5. PubMed ID: 17548889
[TBL] [Abstract][Full Text] [Related]
32. Direct quantification of gamma H2AX by cell-based high throughput screening for evaluation of genotoxicity of pesticides in a human thyroid cell lines.
Hershman JM; France B; Hon K; Damoiseaux R
Environ Mol Mutagen; 2017 Aug; 58(7):522-528. PubMed ID: 28640454
[TBL] [Abstract][Full Text] [Related]
33. Economic benefits of using adaptive predictive models of reproductive toxicity in the context of a tiered testing program.
Martin MT; Knudsen TB; Judson RS; Kavlock RJ; Dix DJ
Syst Biol Reprod Med; 2012 Feb; 58(1):3-9. PubMed ID: 22239076
[TBL] [Abstract][Full Text] [Related]
34. In vitro testing for carcinogens and mutagens.
Santella RM
Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
[TBL] [Abstract][Full Text] [Related]
35. The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides.
Billington R; Lewis RW; Mehta JM; Dewhurst I
Crit Rev Toxicol; 2010 Jan; 40(1):35-49. PubMed ID: 20144135
[TBL] [Abstract][Full Text] [Related]
36. How to assess the mutagenic potential of cosmetic products without animal tests?
Speit G
Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
[TBL] [Abstract][Full Text] [Related]
37. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.
Kirkland DJ; Aardema M; Banduhn N; Carmichael P; Fautz R; Meunier JR; Pfuhler S
Mutagenesis; 2007 May; 22(3):161-75. PubMed ID: 17369606
[TBL] [Abstract][Full Text] [Related]
38. Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells.
Mizota T; Ohno K; Yamada T
Mutat Res; 2011 Sep; 724(1-2):76-85. PubMed ID: 21704725
[TBL] [Abstract][Full Text] [Related]
39. The weight of the evidence among group C carcinogens.
Engler R; Rinde E; Frick C; Quest J
Qual Assur; 1991 Oct; 1(1):51-69. PubMed ID: 1669970
[TBL] [Abstract][Full Text] [Related]
40. Critical evaluation of the cancer risk of dibromochloropropane (DBCP).
Clark HA; Snedeker SM
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(2):215-60. PubMed ID: 16291528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
